Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review.

Respiratory research - 10 Sept 2016

Miravitlles Marc, D'Urzo Anthony, Singh Dave, Koblizek Vladimir

Abstract excerpt

Identifying patients at risk of exacerbations and managing them appropriately to reduce this risk represents an important clinical challenge. Numerous treatments have been assessed for the prevention of exacerbations and their efficacy may differ by patient phenotype. Given their centrality in the treatment of COPD, there is strong rationale for maximizing bronchodilation as an initial strategy to reduce...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Cortex Hormones
Share to Adrenergic beta-2 Receptor Agonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Anti-Bacterial Agents

Share to Bronchodilator Agents

Share to Drug Therapy, Combination

Share to Muscarinic Antagonists

Share to Pulmonary Disease, Chronic Obstructive

Source

Open in PubMed Open full text

Identifiers

PMID: 27613392
DOI: 10.1186/s12931-016-0425-5
PMCID: PMC5018159

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review.PMID 27613392Read ↗

Exacerbations of COPD.Semantic proximity Read ↗

Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice.Semantic proximity Read ↗

COPD exacerbations: causes, prevention, and treatment.Semantic proximity Read ↗

COPD exacerbations: causes, prevention, and treatment.Semantic proximity Read ↗

Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease.Semantic proximity Read ↗

How should we define and classify exacerbations in chronic obstructive pulmonary disease?Semantic proximity Read ↗

Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping.Semantic proximity Read ↗

Efficacy of roflumilast in the COPD frequent exacerbator phenotype.Semantic proximity Read ↗

LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.Semantic proximity Read ↗

Exacerbations of severe asthma.Semantic proximity Read ↗

[Multidimensional impact of COPD exacerbations].Semantic proximity Read ↗

Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.